Yuling Shi

981 total citations
18 papers, 666 citations indexed

About

Yuling Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuling Shi has authored 18 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yuling Shi's work include DNA Repair Mechanisms (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related Molecular Pathways (4 papers). Yuling Shi is often cited by papers focused on DNA Repair Mechanisms (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related Molecular Pathways (4 papers). Yuling Shi collaborates with scholars based in China, United States and Canada. Yuling Shi's co-authors include Randal S. Tibbetts, Gerald E. Dodson, Zhao‐Hui Wu, Guangyun Tan, Jixiao Niu, Kathleen Rundell, Rui Ma, Xin Wang, Sujatha Venkataraman and Angela M. Mabb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Yuling Shi

18 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuling Shi China 12 498 230 167 89 66 18 666
Asaf Rotem United States 14 612 1.2× 124 0.5× 235 1.4× 189 2.1× 89 1.3× 22 920
Huifen Zhu China 15 290 0.6× 72 0.3× 172 1.0× 188 2.1× 136 2.1× 58 684
Manu Tewari United States 11 568 1.1× 190 0.8× 182 1.1× 251 2.8× 74 1.1× 24 971
Jinyu Lu United States 11 514 1.0× 111 0.5× 65 0.4× 122 1.4× 32 0.5× 21 670
Lucas Philippe France 10 558 1.1× 269 1.2× 57 0.3× 102 1.1× 44 0.7× 11 771
Eric W. Mills United States 8 622 1.2× 157 0.7× 81 0.5× 146 1.6× 41 0.6× 11 821
Zhan Wang China 15 245 0.5× 128 0.6× 272 1.6× 307 3.4× 27 0.4× 39 764
Tonghai Dou China 13 349 0.7× 241 1.0× 104 0.6× 88 1.0× 54 0.8× 31 552
Julie M. Lowe United States 10 362 0.7× 142 0.6× 211 1.3× 151 1.7× 42 0.6× 11 581
Mohammed Kanchwala United States 14 356 0.7× 119 0.5× 89 0.5× 101 1.1× 57 0.9× 27 653

Countries citing papers authored by Yuling Shi

Since Specialization
Citations

This map shows the geographic impact of Yuling Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Shi more than expected).

Fields of papers citing papers by Yuling Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuling Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Shi. The network helps show where Yuling Shi may publish in the future.

Co-authorship network of co-authors of Yuling Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuling Shi. A scholar is included among the top collaborators of Yuling Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuling Shi. Yuling Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Yu, et al.. (2023). Circ_0082476 targets miR-138-5p to promote proliferation, invasion, migration and inflammation in IL-22-treated human keratinocytes by upregulating BRD4. International Immunopharmacology. 119. 110095–110095. 4 indexed citations
2.
Shi, Yuling, et al.. (2023). Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma. Gene. 894. 147989–147989. 6 indexed citations
3.
Wang, Xin, Rui Ma, Weimin Shi, Zhouwei Wu, & Yuling Shi. (2021). Emerging roles of circular RNAs in systemic lupus erythematosus. Molecular Therapy — Nucleic Acids. 24. 212–222. 22 indexed citations
4.
Wang, Xin, Rui Ma, Xilin Zhang, et al.. (2021). Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions. Molecular Cancer. 20(1). 121–121. 73 indexed citations
5.
Li, Zhenyan, et al.. (2020). Visualization of GLUT1 Trafficking in Live Cancer Cells by the Use of a Dual-Fluorescence Reporter. ACS Omega. 5(26). 15911–15921. 20 indexed citations
6.
Gui, Tao, et al.. (2020). <p>Combination BET Family Protein and HDAC Inhibition Synergistically Elicits Chondrosarcoma Cell Apoptosis Through RAD51-Related DNA Damage Repair</p>. Cancer Management and Research. Volume 12. 4429–4439. 7 indexed citations
7.
Niu, Jixiao, Yuling Shi, Jingyan Xue, et al.. (2013). USP10 inhibits genotoxic NF‐κB activation by MCPIP1‐facilitated deubiquitination of NEMO. The EMBO Journal. 32(24). 3206–3219. 89 indexed citations
8.
Wu, Zhao‐Hui & Yuling Shi. (2013). When Ubiquitin Meets NF-&kappa;B: A Trove for Anti-cancer Drug Development. Current Pharmaceutical Design. 19(18). 3263–3275. 23 indexed citations
9.
Tan, Guangyun, Jixiao Niu, Yuling Shi, Hongsheng Ouyang, & Zhao‐Hui Wu. (2012). NF-κB-dependent MicroRNA-125b Up-regulation Promotes Cell Survival by Targeting p38α upon Ultraviolet Radiation. Journal of Biological Chemistry. 287(39). 33036–33047. 67 indexed citations
10.
Tan, Guangyun, Yuling Shi, & Zhao‐Hui Wu. (2011). MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. Biochemical and Biophysical Research Communications. 417(1). 546–551. 53 indexed citations
11.
Liu, Jian, Zhaohui Sun, Yuling Shi, Shuyan Wang, & Min Wei. (2010). [Inhibitory effect of siRNA targeting gene Aqp1 on K562 cells].. PubMed. 18(1). 40–4. 1 indexed citations
12.
Sun, Zhaohui, Huilan Yang, Min Wei, et al.. (2007). [Preparation and application of oligo microarrays for hepatitis virus detection and genotyping].. PubMed. 15(11). 816–20. 3 indexed citations
13.
Shi, Yuling, Gerald E. Dodson, Partha Mukhopadhyay, et al.. (2007). Identification of Carboxyl-terminal MCM3 Phosphorylation Sites Using Polyreactive Phosphospecific Antibodies. Journal of Biological Chemistry. 282(12). 9236–9243. 34 indexed citations
14.
Shi, Yuling, et al.. (2005). Ataxia-telangiectasia-mutated (ATM) Is a T-antigen Kinase That Controls SV40 Viral Replication in Vivo. Journal of Biological Chemistry. 280(48). 40195–40200. 83 indexed citations
15.
Dodson, Gerald E., Yuling Shi, & Randal S. Tibbetts. (2004). DNA Replication Defects, Spontaneous DNA Damage, and ATM-dependent Checkpoint Activation in Replication Protein A-deficient Cells. Journal of Biological Chemistry. 279(32). 34010–34014. 78 indexed citations
16.
Shi, Yuling, Sujatha Venkataraman, Gerald E. Dodson, et al.. (2004). Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proceedings of the National Academy of Sciences. 101(16). 5898–5903. 79 indexed citations
17.
Shi, Yuling, Linhai Li, Ping Li, et al.. (2003). [Over-expression in Escherichia coli and purification of nucleocaspid and membrane protein of SARS coronavirus].. PubMed. 19(4). 392–6. 1 indexed citations
18.
Fannin, R. J., YP Vaid, & Yuling Shi. (1994). A Critical Evaluation of the Gradient Ratio Test. Geotechnical Testing Journal. 17(1). 35–42. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026